BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choe WH, Kim YJ, Park HS, Park SW, Kim JH, Kwon SY. Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(35): 12588-12594 [PMID: 25253962 DOI: 10.3748/wjg.v20.i35.12588]
URL: https://www.wjgnet.com/1948-5204/full/v20/i35/12588.htm
Number Citing Articles
1
Hongjun Yuan, Fengyong Liu, Xin Li, Yang Guan, Maoqiang Wang. Angio-CT-Guided Transarterial Chemoembolization Immediately in Combination with Radiofrequency Ablation for Large Hepatocellular CarcinomaAcademic Radiology 2019; 26(2): 224 doi: 10.1016/j.acra.2018.04.007
2
Feng Duan, Yan-Hua Bai, Li Cui, Xiao-Hui Li, Jie-Yu Yan, Mao-Qiang Wang. Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2020; 12(1): 92-100 doi: 10.4251/wjgo.v12.i1.92
3
Lumin Chen, Jihong Sun, Xiaoming Yang. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current statusCancer Letters 2016; 370(1): 78 doi: 10.1016/j.canlet.2015.09.020
4
Shiji Fang, Linqiang Lai, Jinyu Zhu, Liyun Zheng, Yuanyuan Xu, Weiqian Chen, Fazong Wu, Xulu Wu, Minjiang Chen, Qiaoyou Weng, Jiansong Ji, Zhongwei Zhao, Jianfei Tu. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency AblationFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.662366
5
Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progressionInternational Journal of Hyperthermia 2022; 39(1): 1 doi: 10.1080/02656736.2021.1998660
6
Yanqiao Ren, Yanyan Cao, Hong Ma, Xuefeng Kan, Chen Zhou, Jiacheng Liu, Qin Shi, Gansheng Feng, Bin Xiong, Chuansheng Zheng. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control studyBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6237-5
7
Robert J. Wong, Aijaz Ahmed, Robert G. Gish. Elevated Alpha-FetoproteinClinics in Liver Disease 2015; 19(2): 309 doi: 10.1016/j.cld.2015.01.005
8
Jie‐Yu Yan, Jin‐Long Zhang, Mao‐Qiang Wang, Kai Yuan, Yan‐Hua Bai, Yan Wang, Hai‐Nan Xin, Zhi‐Jun Wang, Feng‐Yong Liu, Feng Duan, Jin‐Xin Fu. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single‐session for solitary hepatocellular carcinoma larger than 7 cmAsia-Pacific Journal of Clinical Oncology 2018; 14(4): 300 doi: 10.1111/ajco.12817
9
Mi Hye Yu, Young Jun Kim, Hee Sun Park, Sung Il Jung, Hae Jeong Jeon, Gianfranco D. Alpini. Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factorsPLOS ONE 2019; 14(2): e0210667 doi: 10.1371/journal.pone.0210667
10
Sae Hwan Lee. Curative Loco-regional Therapies for Early Hepatocellular Carcinoma: Is Combination Effective?The Korean Journal of Gastroenterology 2019; 73(3): 121 doi: 10.4166/kjg.2019.73.3.121
11
Jie Tan, René Michael Mathy, De-Hua Chang, Tian Tang, Zi-Shu Zhang, Yu-Dong Xiao. Combined transarterial iodized oil injection and computed tomography-guided thermal ablation for hepatocellular carcinoma: utility of the iodized oil retention patternAbdominal Radiology 2022; 47(1): 431 doi: 10.1007/s00261-021-03305-3
12
Roberto Iezzi, Maurizio Pompili, Alessandro Posa, Giuseppe Coppola, Antonio Gasbarrini, Lorenzo Bonomo. Combined locoregional treatment of patients with hepatocellular carcinoma: State of the artWorld Journal of Gastroenterology 2016; 22(6): 1935-1942 doi: 10.3748/wjg.v22.i6.1935
13
Zongyi Yin, Dongying Chen, Shuang Liang, Xiaowu Li. Neoadjuvant Therapy for Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 929 doi: 10.2147/JHC.S357313
14
Wooil Kim, Sung Ki Cho, Sung Wook Shin, Dongho Hyun, Min Woo Lee, Hyunchul Rhim. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapyAbdominal Radiology 2019; 44(6): 2283 doi: 10.1007/s00261-019-01952-1
15
Enrico Boninsegna, Emilio Simonini, Stefano Crosara, Michela De Angelis, Luigi Boccia, Stefano Colopi. Large Multifocal Hepatocarcinoma: Technical Details of Treatment with Combined Transarterial Chemoembolization, Microwave and Radiofrequency AblationJournal of Gastrointestinal Cancer 2021; 52(1): 300 doi: 10.1007/s12029-020-00416-w
16
Xin Zheng, Yanqiao Ren, Hanqing Hu, Kun Qian. Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.713432
17
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinomaThe Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
18
Lin Zheng, Hai-Liang Li, Chen-Yang Guo, Su-Xia Luo. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular CarcinomasKorean Journal of Radiology 2018; 19(2): 237 doi: 10.3348/kjr.2018.19.2.237
19
Liangliang Yan, Yanqiao Ren, Kun Qian, Xuefeng Kan, Hongsen Zhang, Lei Chen, Bin Liang, Chuansheng Zheng. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative studyBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01765-x
20
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie, Zhimin Suo. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparisonOncotarget 2017; 8(9): 15101 doi: 10.18632/oncotarget.13145
21
Ah Ran Kim, Eugene Park, So Young Kwon, Seong Jun Park, Young Jung Kim, Byung Chul Yoo, Won Hyeok Choe, Jeong Han Kim, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi hye Yu, Hae jeong Jeon. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative TreatmentThe Korean Journal of Gastroenterology 2019; 73(3): 167 doi: 10.4166/kjg.2019.73.3.167
22
Jae Min Park, Won Hyeok Choe, Jeong Han Kim, So Young Kwon, Byung Chul Yoo. The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinomaJournal of Liver Cancer 2021; 21(2): 155 doi: 10.17998/jlc.2021.09.22